Arkema S.A. Reports Q3 Growth with Increased Net Income and Sales
Arkema S.A. reported a strong third quarter, highlighted by an 8.1% year-over-year increase in sales, reaching €2.4 billion. This growth was driven primarily by higher pricing strategies and resilient sales volumes, particularly within the United States market. The company's adjusted net income saw significant improvement, rising to €93 million, which equates to €1.23 per share. Despite facing a generally weak global demand environment and difficult operating conditions in certain regions, Arkema managed to maintain positive momentum through its pricing power.
Tickers: $ARKAY
Topics: net income revenue growth sales performance
Read the full article at Seeking Alpha
Part of the story Niagen Reports Q3 2026 Net Loss Amid Declining Sales and Increased Competition (8 articles)